Pathway enrichment results did not clearly indicate the nature of the association of TAARs with identified biological processes, and the results were insufficient to determine if TAAR6 was implicated in cancer-associated pathways, or TAAR6 only co-regulates with mTOR signaling in tumors. The gene discussed is MTOR; the disease is cancer.